NCT05859451

Brief Summary

The goal of this clinical trial is to investigate the role of switching from cigarette smoking (CS) to tobacco heat system (THS) on the clinical outcome of closed lower limb (tibia and femur) fractures from smokers' orthopedic patients. Validated and standardized assays, medical state and self-reported outcomes will be evaluated in orthopedic patients' smokers or switch from CS to using THS throughout six months compare to ex-smokers (control).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 30, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 16, 2023

Completed
17 days until next milestone

Study Start

First participant enrolled

June 2, 2023

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 17, 2026

Completed
Last Updated

December 11, 2024

Status Verified

December 1, 2024

Enrollment Period

2.4 years

First QC Date

March 30, 2023

Last Update Submit

December 5, 2024

Conditions

Keywords

Bone healingTobacco heating systemSmoking cessation

Outcome Measures

Primary Outcomes (1)

  • Concentration of Procollagen Type 1 N-Terminal Propeptide (CICP)

    Marker collagen formation - bone formation

    6 months after tibia fracture surgery

Secondary Outcomes (18)

  • Concentration of Alkaline Phosphatase (BAP)

    6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  • Concentration of Osteoprogesterin

    6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  • Concentration of Osteopontin

    6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  • Concentration of N-terminal telopeptide (NTx)

    6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  • Concentration of Interleukin 1 beta (IL-1β)

    6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  • +13 more secondary outcomes

Other Outcomes (15)

  • Concentration of Soluble intercellular adhesion molecule-1 (sICAM-1)

    6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  • Concentration of High densitiy lipoprotein cholesterol levels (HDL)

    6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  • Concentration of Leucocytes

    6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

  • +12 more other outcomes

Study Arms (3)

Smokers

NO INTERVENTION

Participants subject to an orthopedic surgery (does not want to quit smoking conventional cigarettes) will continue smoking conventional cigarettes ad libitum for a period of 6 month post surgery

Smokers willing to switch to THS

EXPERIMENTAL

Participants subject to an orthopedic surgery (currently smoking conventional cigarettes) will start to used THS ad libitum for a period of 6 month post surgery

Device: Tobacco Heating System (THS)

Ex Smokers

ACTIVE COMPARATOR

Participants subject to an orthopedic surgery will not smoke cigarettes or use electronic nicotine deliver systems for a period of 6 month post surgery

Other: Smoking abstinence

Interventions

Participant who are not willing to quit cigarette smoking during the study duration will switch from cigarettes to using THS

Also known as: IQOS 3 DUO
Smokers willing to switch to THS

Participant who are willing to quit cigarette smoking and will not use any electronic nicotine delivery system during the study duration

Ex Smokers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Closed tibia or femur fracture (according to AO/OTA: 41A2-41C3, 42A-C, 43A-C, 32A-C, 33A2-3, 33B-C) which is surgically treated within 14 days after the trauma at the BG trauma clinic Tübingen.
  • Smokers with 10-20 packyears smoking history.
  • Smoking history \>10 years.
  • Decision not to participate in the free smoking cessation seminars.

You may not qualify if:

  • Legal guardian or loss of capacity to consent.
  • Refusal to participate in the study.
  • Open fractures or concomitant injuries or complications requiring surgery existing at the time of surgical indication.
  • Initial surgical treatment of the fracture has occurred ex domo.
  • No initial surgical treatment within 14 days of sustained trauma.
  • Using nicotine delivery electronic devices.
  • Pre-existing autoimmune, immunological, bone or malignant diseases.
  • Pregnant, breastfeeding and women of childbearing age with existing desire to have children.
  • History of alcohol abuse or drug abuse.
  • Taking antioxidants approval by the German Federal Institute for Drugs and Medical Devices (BfArM).
  • Taking drugs with known effect on bone metabolism (according to Institute for medical and pharmaceutical examination issues (IMPP): allosteric CaSR modulators, bisphosphonates, calcium release inhibitors, alkaline earth ions, RANKL inhibitors, calcitriol, colecalciferol).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Siegfried Weller Institutes, BG-Trauma Clinic, Department of Traumatology, Eberhard Karls University Tübingen

Tübingen, Baden-Wurttemberg, 72076, Germany

RECRUITING

Related Publications (3)

  • Aspera-Werz RH, Ehnert S, Muller M, Zhu S, Chen T, Weng W, Jacoby J, Nussler AK. Assessment of tobacco heating system 2.4 on osteogenic differentiation of mesenchymal stem cells and primary human osteoblasts compared to conventional cigarettes. World J Stem Cells. 2020 Aug 26;12(8):841-856. doi: 10.4252/wjsc.v12.i8.841.

    PMID: 32952862BACKGROUND
  • Weng W, Bovard D, Zanetti F, Ehnert S, Braun B, Uynuk-Ool T, Histing T, Hoeng J, Nussler AK, Aspera-Werz RH. Tobacco heating system has less impact on bone metabolism than cigarette smoke. Food Chem Toxicol. 2023 Mar;173:113637. doi: 10.1016/j.fct.2023.113637. Epub 2023 Jan 25.

    PMID: 36708864BACKGROUND
  • Moritz Herbst, Romina Aspera-Werz, Benedikt Braun, Kevin Schulz, et al. (2024). Evaluation of the Tobacco Heating System (THS) During Closed Lower Limb Fracture Healing in Trauma Smokers' Patients. Qeios. doi:10.32388/DE0EAE.2.

    BACKGROUND

MeSH Terms

Conditions

SmokingTibial FracturesSmoking Cessation

Condition Hierarchy (Ancestors)

BehaviorFractures, BoneWounds and InjuriesLeg InjuriesHealth Behavior

Central Study Contacts

Andreas K. Nüssler, Prof. Dr.

CONTACT

Benedikt J. Braun, PD. Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Profesor Doctor

Study Record Dates

First Submitted

March 30, 2023

First Posted

May 16, 2023

Study Start

June 2, 2023

Primary Completion

October 15, 2025

Study Completion

April 17, 2026

Last Updated

December 11, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

All IPD (in an anonymous form) that underlie results in a publication

Shared Documents
STUDY PROTOCOL
Time Frame
6 months after results are published in peer-reviewed international journal

Locations